ACT Genomics Completes Acquisition of MC Diagnostics
HONG KONG, Jul 6, 2021 – (ACN Newswire via SEAPRWire.com) – ACT Genomics Co. Ltd. (“ACT Genomics” or “the Group”) has completed the acquisition of MC Diagnostics Ltd. (“MCD”), a […]
Singapore researchers develop blood test for cancer treatment and detection
SINGAPORE – Researchers in Singapore have developed a blood test which will not only allow doctors to determine the effectiveness of cancer treatment within 24 hours, but also detect the […]
Eisai and National Cancer Center Commence Joint Research and Development Project
TOKYO, May 14, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and the National Cancer Center Japan announced today that both parties have entered into a joint research […]
The business of ‘female tech’ is growing
(NYTIMES) – Women represent half of the planet’s population. Yet tech companies catering to their specific health needs represent a minute share of the global tech market. Tapping that spending […]
Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Uterine Body Cancer in Japan
TOKYO, Apr 23, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and MSD K.K., a subsidiary of Merck & Co., Inc., Kenilworth, N.J., U.S.A., (known as MSD outside […]
Ministry of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Anti-Cancer Agent Lenvima (Lenvatinib) With Prospective Indication for Uterine Body Cancer
TOKYO, Mar 12, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that it has received orphan drug designation for LENVIMA (generic name: lenvatinib mesylate), the orally […]
NEC Joins the CONNECT Landmark Public-private Initiative for Precision Cancer Medicine
TOKYO, Mar 8, 2021 – (JCN Newswire via SEAPRWire.com) – NEC Corporation (TSE: 6701) today announced that it has joined a landmark public-private initiative, the Norwegian Precision Cancer Medicine Implementation […]
Eisai: MHLW Grants Orphan Drug Designation in Japan to Novel FGF Receptor Selective Tyrosine Kinase Inhibitor E7090
TOKYO, Feb 22, 2021 – (JCN Newswire) – Eisai Co., Ltd. announced today that it has received orphan drug designation for a prospective indication for unresectable biliary tract cancer with […]
Olympus Supports Dissemination of Endoscopic Procedures for Colorectal Cancer in Russia
TOKYO, Feb 4, 2021 – (ACN Newswire) – Olympus Corporation (Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) announced today that it has been selected(1) by Japan’s Ministry of […]
Broncus Holding Corporation Closed Series D Financing
HONG KONG, Jan 28, 2021 – (ACN Newswire) – Broncus Holding Corporation (“Broncus”), a global leader in diagnostic and therapeutic technology for lung diseases, announced today the closing of a […]
Eisai to Present Abstracts on Lenvatinib at 2021 Gastrointestinal Cancers Symposium
TOKYO, Jan 12, 2021 – (JCN Newswire) – Eisai Co., Ltd. has announced that presentations on a series of abstracts highlighting updates on its in-house discovered lenvatinib mesylate (product name: […]
ESM Goh Chok Tong has cancer surgery, will undergo 4 weeks of radiotherapy
SINGAPORE – Emeritus Senior Minister Goh Chok Tong will be undergoing four weeks of radiotherapy following the removal of a lump in his larynx. This is to ensure that all […]
Parents collect PSLE results of son who died from cancer
SINGAPORE – In 2008, when he was but an eight-month-old baby, Raphael Lee was diagnosed with rhabdomyosarcoma in his left forearm. He underwent treatment for this rare form of soft […]